GURUFOCUS.COM » STOCK LIST » Technology » Software » Core Scientific Inc (OTCPK:CORZQ) » Definitions » Peter Lynch Fair Value

Core Scientific (Core Scientific) Peter Lynch Fair Value : N/A (As of Jun. 01, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Core Scientific Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Core Scientific's Peter Lynch Fair Value or its related term are showing as below:



CORZQ's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Software industry.
Industry Median: 1.47
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Core Scientific Peter Lynch Fair Value Historical Data

The historical data trend for Core Scientific's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Scientific Peter Lynch Fair Value Chart

Core Scientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
- - - - -

Core Scientific Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Core Scientific's Peter Lynch Fair Value

For the Software - Infrastructure subindustry, Core Scientific's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core Scientific's Price-to-Peter-Lynch-Fair-Value Distribution in the Software Industry

For the Software industry and Technology sector, Core Scientific's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Core Scientific's Price-to-Peter-Lynch-Fair-Value falls into.



Core Scientific Peter Lynch Fair Value Calculation

Core Scientific's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *0
=N/A

Core Scientific's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $0.00.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Core Scientific  (OTCPK:CORZQ) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

Core Scientific's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=0.89/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Core Scientific Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Core Scientific's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Core Scientific (Core Scientific) Business Description

Traded in Other Exchanges
Address
210 Barton Springs Road, Austin, TX, USA, 78704
Core Scientific Inc is engaged in Blockchain and AI Infrastructure, Digital Asset Self-Mining, Premium Hosting, Blockchain Technology, and Artificial Intelligence related services. The business operates in two segments being; Equipment Sales and Hosting which consists of blockchain infrastructure, third-party hosting business and equipment sales to customers. Mining segment consists of digital asset mining for its account. The blockchain business generates revenue from the sale of consumption-based contracts and by providing hosting services. The digital asset mining segment earns revenue from operating a firm's owned computer equipment as part of a pool of users that process transactions conducted on one or more blockchain networks. In exchange, it receives digital currency assets.
Executives
Adam Taylor Sullivan officer: President C/O CORE SCIENTIFIC, INC., 2407 S. CONGRESS AVENUE, AUSTIN TX 78704
Darin Feinstein director, 10 percent owner, officer: Chief Vision Officer 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Sterling Denise Marie Brucia officer: Chief Financial Officer C/O CORE SCIENTIFIC, INC., 201 BARTON SPRINGS ROAD, AUSTIN TX 78704
Matt Minnis director 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Brian Neville officer: Chief Accounting Officer C/O CORE SCIENTIFIC, INC., 2800 NORTHROP WAY, BELLEVUE WA 98004
Todd M Duchene officer: EVP, GC and Secretary 847 GIBRALTAR DR., MILPITAS CA 95035
Michael Trzupek officer: Chief Financial Officer 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Stacie Olivares director 2525 E. CAMELBACK RD., STE 850, PHOENIX AZ 85016
Jarvis V. Hollingsworth director 100 WEST HOUSTON STREET, SAN ANTONIO TX 78205
Michael J Levitt director, officer: Chief Executive Officer KAYNE ANDERSON CAPITAL ADVISORS, L.P., 1800 AVENUE OF THE STARS, 3RD FLOOR, LOS ANGELES CA 90067
Dr Kneeland Youngblood director C/O GAP, INC., 2 FOLSOM ST., SAN FRANCISCO CA 94105
John P Mcgarrity officer: General Counsel and Secretary 321 N. CLARK STREET, CHICAGO IL 60054
Sullivan Colleen director 420 EXECUTIVE SQUARE SUITE 300, LA JOLLA CA 92037
Theodore J Brombach 10 percent owner 321 N. CLARK STREET, CHICAGO IL 60054
Patrick C Eilers director, 10 percent owner, officer: Chief Executive Officer THREE FIRST NATIONAL PLAZA STE 3800, CHICAGO IL 60602

Core Scientific (Core Scientific) Headlines

From GuruFocus